Standard
The incretin/glucagon system as a target for pharmacotherapy of obesity. / Del Prato, Stefano; Gallwitz, Baptist; Holst, Jens Juul; Meier, Juris J.
In:
Obesity Reviews, Vol. 23, No. 2, e13372, 2022.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Del Prato, S, Gallwitz, B
, Holst, JJ & Meier, JJ 2022, '
The incretin/glucagon system as a target for pharmacotherapy of obesity',
Obesity Reviews, vol. 23, no. 2, e13372.
https://doi.org/10.1111/obr.13372APA
Del Prato, S., Gallwitz, B.
, Holst, J. J., & Meier, J. J. (2022).
The incretin/glucagon system as a target for pharmacotherapy of obesity.
Obesity Reviews,
23(2), [e13372].
https://doi.org/10.1111/obr.13372Vancouver
Del Prato S, Gallwitz B
, Holst JJ, Meier JJ.
The incretin/glucagon system as a target for pharmacotherapy of obesity.
Obesity Reviews. 2022;23(2). e13372.
https://doi.org/10.1111/obr.13372Author
Del Prato, Stefano ; Gallwitz, Baptist ; Holst, Jens Juul ; Meier, Juris J. / The incretin/glucagon system as a target for pharmacotherapy of obesity. In: Obesity Reviews. 2022 ; Vol. 23, No. 2.
Bibtex
@article{17327ba7946c43bda114170647c8aba0,
title = "The incretin/glucagon system as a target for pharmacotherapy of obesity",
keywords = "dual agonist, GLP-1, glucagon, overweight",
author = "{Del Prato}, Stefano and Baptist Gallwitz and Holst, {Jens Juul} and Meier, {Juris J.}",
year = "2022",
doi = "10.1111/obr.13372",
language = "English",
volume = "23",
journal = "Obesity Reviews",
issn = "1467-7881",
publisher = "Wiley-Blackwell",
number = "2",
}
RIS
TY - JOUR
T1 - The incretin/glucagon system as a target for pharmacotherapy of obesity
AU - Del Prato, Stefano
AU - Gallwitz, Baptist
AU - Holst, Jens Juul
AU - Meier, Juris J.
PY - 2022
Y1 - 2022
KW - dual agonist
KW - GLP-1
KW - glucagon
KW - overweight
U2 - 10.1111/obr.13372
DO - 10.1111/obr.13372
M3 - Journal article
C2 - 34713962
VL - 23
JO - Obesity Reviews
JF - Obesity Reviews
SN - 1467-7881
IS - 2
M1 - e13372
ER -
